Nuvalent, Inc. (NUVL)

99.41 -0.72 (-0.72%) USD  |  NASDAQ  |  Mar 06, 16:00
99.34 -0.07 (-0.07%) After-Hours: 20:00
More

Nuvalent Repurchase of Capital Stock (Annual Per Share)

Repurchase of Capital Stock (Annual Per Share) Chart

View Repurchase of Capital Stock (Annual Per Share) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Repurchase of Capital Stock (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Repurchase of Capital Stock (Annual Per Share) Range, Past 5 Years

View Repurchase of Capital Stock (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Repurchase of Capital Stock (Annual Per Share) Benchmarks

View Repurchase of Capital Stock (Annual Per Share) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Kodiak Sciences, Inc. Upgrade